Hikma Pharmaceuticals PLCHIK:LSE

5.00 / 0.22 %
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of May 05 2016 16:35 BST.


On Thursday, Hikma Pharmaceuticals PLC (HIK:LSE) closed at 2,259, 10.36 % below its 52-week high of 2,520, set on Aug 19, 2015.

52-week range
Mar 16 2016
Aug 19 2015
Markit short selling activity
Day high2,277
Day low2,245
Previous close2,264
Average volume521.37k
Shares outstanding239.39m
Free float133.52m
P/E (TTM)26.23
Market cap5.44bn GBP
EPS (TTM)0.8655 GBP
Annual div (IAD)21.74 GBX
Annual div yield (IAD)0.96%
Div ex-dateApr 07 2016
Div pay-dateMay 19 2016
Data delayed at least 15 minutes, as of May 05 2016 16:35 BST.
Last IC View
The last IC recommendation on Hikma Pharmaceuticals PLC shares was Hold at 1,620 on 16 Mar 2016
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Hikma Pharmaceuticals PLC+0.80 %+11.17 %+10.30 %+11.61 %+189.49 %
FTSE 100 IDX-3.24 %+0.43 %-3.89 %-11.70 %+3.33 %
GB/HEALTH CARE-3.26 %-0.45 %-4.12 %-11.24 %+21.29 %
GB/PHARMACEUTICALS-3.24 %-0.20 %-4.56 %-12.10 %+19.97 %
Data delayed at least 15 minutes, as of May 05 2016 16:35 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.